The market regulator has once again extended the deadline for registered entities (REs) to adopt Cybersecurity and Cyber Resilience Framework (CSCRF), except for market infrastruc ...

BMS is already testing the combo against just Keytruda as a first-line treatment in a Phase III trial in KRAS G12C-mutant and ...

These days, along with the relief of having a stable job, comes a load of added stress- with work pressure mounting up day on ...

The capital markets regulator has extended the deadline for regulated entities to implement the Cybersecurity and Cyber ...

The decision to expand the development plan follows recently reported promising preclinical findings demonstrating that ...

From April 1, SEBI, India's securities regulator, is set to implement a transformative measure aimed at mitigating unclaimed assets (UA) in the Indian securities market.

SEBI's tie-up with DigiLocker aims to bring down the number of stock and mutual fund holdings that remain unclaimed.

Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCCUpdated data from ongoing Phase 1/1b trial in 1L ...

GTPase KRAS G12D mutant and/or G12V mutant inhibitors potentially useful for the treatment of cancer have been detailed in a Quanta Therapeutics Inc.

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Cardiff ...